Literature DB >> 19687529

Second national serum bank for population-based seroprevalence studies in the Netherlands.

F R M van der Klis1, L Mollema, G A M Berbers, H E de Melker, R A Coutinho.   

Abstract

In 2006/2007 a large serum bank was established by means of a cross-sectional population-based study. This serum bank will be used to evaluate the Dutch national immunisation programme (NIP) by serosurveillance and additional immunological and epidemiological research. In this paper we describe the design of this population-based cross-sectional serosurvey and report the participation rates as well as general characteristics of the study population. A similar serum bank was collected in 1995/1996. Dutch inhabitants (aged 0-79 years, men and women) were invited from 40 municipalities throughout the country and also from eight additional municipalities known with low vaccination coverage (LVC). An oversampling of the migrant population was performed. Blood samples were obtained from all participants accompanied with extensive information on demographic and epidemiological data, such as vaccination history, risk factors and travelling. In addition, sociodemographic data are available from individuals who declined to participate (non-response survey). Overall 33% of all invitees were included in this study. The serum bank comprises 6386 sera in the nationwide sample including the extra sample of immigrants (n=646) and 1518 sera from the LVC municipalities. The sera will be analysed for antibodies against all NI P antigens but will also be used for other infectious diseases research. Results of this second serosurveillance study will contribute to the discussion whether it is needed to reconsider the schedule and/or the vaccine components of the current National Immunisation Programme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19687529

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  40 in total

1.  Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.

Authors:  Gaby P Smits; Pieter G van Gageldonk; Leo M Schouls; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2012-01-11

Review 2.  The role of seroepidemiology in the comprehensive surveillance of vaccine-preventable diseases.

Authors:  Sarah E Wilson; Shelley L Deeks; Todd F Hatchette; Natasha S Crowcroft
Journal:  CMAJ       Date:  2011-11-14       Impact factor: 8.262

3.  Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid.

Authors:  Pieter G M van Gageldonk; Christina von Hunolstein; Fiona R M van der Klis; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

4.  Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands.

Authors:  R Bodewes; G de Mutsert; F R M van der Klis; M Ventresca; S Wilks; D J Smith; M Koopmans; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  Clin Vaccine Immunol       Date:  2011-01-05

5.  Primary Human Influenza B Virus Infection Induces Cross-Lineage Hemagglutinin Stalk-Specific Antibodies Mediating Antibody-Dependent Cellular Cytoxicity.

Authors:  Rory D de Vries; Nella J Nieuwkoop; Fiona R M van der Klis; Marion P G Koopmans; Florian Krammer; Guus F Rimmelzwaan
Journal:  J Infect Dis       Date:  2017-12-27       Impact factor: 5.226

6.  Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.

Authors:  Susanne P Stoof; Mariëtte B van Ravenhorst; Debbie M van Rooijen; Richarda M de Voer; Fiona R M van der Klis; Greet J Boland; Elisabeth A M Sanders; Guy A M Berbers; Peter F Teunis
Journal:  Clin Vaccine Immunol       Date:  2017-02-06

7.  Seroepidemiology of human Toxocara and Ascaris infections in the Netherlands.

Authors:  Lapo Mughini-Gras; Margriet Harms; Wilfrid van Pelt; Elena Pinelli; Titia Kortbeek
Journal:  Parasitol Res       Date:  2016-05-27       Impact factor: 2.289

8.  Comparison of different assays to assess human papillomavirus (HPV) type 16- and 18-specific antibodies after HPV infection and vaccination.

Authors:  Mirte Scherpenisse; Rutger M Schepp; Madelief Mollers; Sofie H Mooij; Chris J L M Meijer; Guy A M Berbers; Fiona R M van der Klis
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

9.  Prevalence of livestock-associated MRSA in communities with high pig-densities in The Netherlands.

Authors:  Brigitte A van Cleef; Erwin J M Verkade; Mireille W Wulf; Anton G Buiting; Andreas Voss; Xander W Huijsdens; Wilfrid van Pelt; Mick N Mulders; Jan A Kluytmans
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

10.  Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.

Authors:  Sandra Waaijenborg; Susan J M Hahné; Liesbeth Mollema; Gaby P Smits; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker; Jacco Wallinga
Journal:  J Infect Dis       Date:  2013-05-08       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.